首届NIH归国学者高峰论坛

2016-09-08 MedSci MedSci原创












版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1662873, encodeId=ad0f16628e33e, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Tue Oct 25 07:34:00 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536910, encodeId=52371536910e9, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sat Sep 10 02:34:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114131, encodeId=83ef1141317a, content=继续关注!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:26:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114129, encodeId=a59b11412935, content=这个值的学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114130, encodeId=e15a11413054, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1662873, encodeId=ad0f16628e33e, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Tue Oct 25 07:34:00 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536910, encodeId=52371536910e9, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sat Sep 10 02:34:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114131, encodeId=83ef1141317a, content=继续关注!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:26:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114129, encodeId=a59b11412935, content=这个值的学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114130, encodeId=e15a11413054, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-10 宋威
  3. [GetPortalCommentsPageByObjectIdResponse(id=1662873, encodeId=ad0f16628e33e, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Tue Oct 25 07:34:00 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536910, encodeId=52371536910e9, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sat Sep 10 02:34:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114131, encodeId=83ef1141317a, content=继续关注!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:26:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114129, encodeId=a59b11412935, content=这个值的学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114130, encodeId=e15a11413054, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 知难而进

    继续关注!!!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1662873, encodeId=ad0f16628e33e, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Tue Oct 25 07:34:00 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536910, encodeId=52371536910e9, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sat Sep 10 02:34:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114131, encodeId=83ef1141317a, content=继续关注!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:26:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114129, encodeId=a59b11412935, content=这个值的学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114130, encodeId=e15a11413054, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 知难而进

    这个值的学习!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1662873, encodeId=ad0f16628e33e, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Tue Oct 25 07:34:00 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536910, encodeId=52371536910e9, content=<a href='/topic/show?id=2dd4128010e' target=_blank style='color:#2F92EE;'>#NIH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12801, encryptionId=2dd4128010e, topicName=NIH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cd212750364, createdName=宋威, createdTime=Sat Sep 10 02:34:00 CST 2016, time=2016-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114131, encodeId=83ef1141317a, content=继续关注!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:26:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114129, encodeId=a59b11412935, content=这个值的学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=114130, encodeId=e15a11413054, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Thu Sep 08 15:25:00 CST 2016, time=2016-09-08, status=1, ipAttribution=)]
    2016-09-08 知难而进

    谢谢分享!

    0

相关资讯

詹启敏院士:2016诺贝尔奖获得者医学峰会暨中美院士论坛

欢迎来到2016诺贝尔奖获得者医学峰会暨中美院士论坛,活动家为您详细介绍会议详情。
诺贝尔奖获得者医学峰会(WORLDNOBELPRIZELAUREATESUMMIT)是由中国科学技术协会、中华中医药协会、中国医师协会、诺贝尔奖得主国际科学交流协会(缩写ISSCNL)在中国举办的年度国际医学盛会。参会者主要包括国家领导人、诺贝尔奖获得者、政府部门相关领导,全国各级医疗机构院长、主任、临床医生,国内外生物医药及器械企业高层、科研人员、研发人员等。峰会设立专题论坛、分会场和展览等系列活动。每届峰会根据当下最热议的医学论点为参考,确定最具代表型的大会主题。进而依托诺奖得主和国内强大的专家团队为技术力量,充分结合国内外最先进的临床知识和技术,为国内外医疗机构做精准的学术剖析和专业学术指导

詹启敏:健康大数据将成为未来很大的数据



在健康报社、中国信息通信研究院、贵阳日报传媒集团联合主办的“从理念到应用——健康大数据高峰论坛”上,中国工程院院士、北京大学医学部主任詹启敏教授作为一位大数据的粉丝,讲述了他对健康大数据的理解,整个报告感染力极强,难寻尿点。报告之后,现场嘉宾、听众、媒体纷纷加入大数据“粉丝团”,气氛热烈。

詹启敏认为,大健康发展策略应该是关注生命全过程,即从生命出生第一天开始,一直到生命的终结。正因为人类的存在,会与社会、环境、微生物、气候产生互动,而这些互动就会导致健康的改变,因而会生成大量的与健康相关的数据,由此推断,健康大数据将会在数量、价值等方面超越其他领域。